MiR-1-3p can inhibit the proliferation and colony forming ability of PCa cells, decrease the expression levels of cyclin-dependent kinase 2 (CDK2) and cyclin-dependent kinase 4 (CDK4), and make more cells stay in the G0/1 phase. This evidence concerns the gene CDK2 and posterior cortical atrophy.